219 related articles for article (PubMed ID: 33034134)
1. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
Zhang Y; Zhu S; Yi L; Liu Y; Cui H
Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
[TBL] [Abstract][Full Text] [Related]
5. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
8. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
[TBL] [Abstract][Full Text] [Related]
9. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Kim JT; Weiss HL; Evers BM
Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
[TBL] [Abstract][Full Text] [Related]
13. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
[No Abstract] [Full Text] [Related]
15. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
16. Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.
Akter H; Yoon JH; Yoo YS; Kang MJ
Mol Cells; 2018 Jun; 41(6):591-602. PubMed ID: 29794962
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.
Olszewski U; Hamilton G
Mol Oncol; 2009 Jun; 3(3):204-13. PubMed ID: 19393580
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
20. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.
Dupouy S; Mourra N; Doan VK; Gompel A; Alifano M; Forgez P
Biochimie; 2011 Sep; 93(9):1369-78. PubMed ID: 21605619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
